Update on review of Besremi for the treatment of PV in Ireland

The NCPE, the body that assesses and recommends drugs for use by the health services in Ireland, has recently released initial advice following their assessment of ropeginterferon alfa-2b (Besremi) for the treatment of patients with Polycythaemia Vera. As part of that assessment process MPN Voice made a patient group submission highlighting the benefits of Besremi…

Interferon supplies – Update 19 August 2024

Interferon supplies – Update 19 August 2024 For some time we have been aware that there are international shortages of interferon alpha, in particular pegasys (pegylated interferon alpha 2a). We have been liaising via our medical team with the national pharmacy and procurement teams looking at advice and options.  This includes the possibility of using…

Shortage of Pegasys Interferon

We are aware that some countries may be experiencing a shortage in the supply of Pegasys Interferon and would like to reassure you various UK Health Bodies and MPN experts have this under review and that it is not an immediate problem in the UK. We will update further once we have more information.

Calling All Young MPN Patients!

Were you diagnosed with an MPN (Myeloproliferative Neoplasm) before the age of 40?  We want to hear from YOU! Your experiences are invaluable in helping us improve our resources and support for young MPN patients. Please share your thoughts on our latest leaflet – read here – and take just 2 minutes to complete our…